Abstract:Numerous studies have proved that cell-nonautonomous regulation of neoplastic cells is a distinctive and essential characteristic of tumorigenesis. Two way communications between the tumor and the stroma, or within the tumor significantly influence disease progression and modify treatment responses. In the tumor microenvironment (TME), malignant cells utilize paracrine signaling initiated by adjacent stromal cells to acquire resistance against multiple types of anticancer therapies, wherein extracellular vesicles (EVs) substantially promote such events. EVs are nanoscaled particles enclosed by phospholipid bilayers, and can mediate intercellular communications between cancerous cells and the adjacent microenvironment to accelerate pathological proceeding. Here we review the most recent studies of EV biology and focus on key cell lineages of the TME and their EV cargoes that are biologically active and responsible for cancer resistance, including proteins, RNAs, and other potentially essential components. Since EVs are emerging as novel but critical elements in establishing and maintaining hallmarks of human cancer, timely and insightful understanding of their molecular properties and functional mechanisms would pave the road for clinical diagnosis, prognosis, and effective targeting in the global landscape of precision medicine. Further, we address the potential of EVs as promising biomarkers in cancer clinics and summarize the technical improvements in EV preparation, analysis, and imaging. We highlight the practical issues that should be exercised with caution to guide the development of targeting agents and therapeutic methodologies to minimize cancer resistance driven by EVs, thereby allowing to effectively control the early steps of disease exacerbation.

Modulatory effects of cancer stem cell-derived extracellular vesicles on the tumor immune microenvironment

The key roles of cancer stem cell-derived extracellular vesicles

Tumor-Derived Extracellular Vesicles Regulate Cancer Progression in the Tumor Microenvironment

Extracellular vesicles remodel tumor environment for cancer immunotherapy

Extracellular vesicles and the regulation of tumor immunity: Current progress and future directions

Extracellular vesicles derived from immune cells: Role in tumor therapy

Cross-talk between cancer stem cells and immune cells: potential therapeutic targets in the tumor immune microenvironment

Extracellular vesicles in the tumor microenvironment: Therapeutic resistance, clinical biomarkers, and targeting strategies

Exploring the dynamic interplay between cancer stem cells and the tumor microenvironment: implications for novel therapeutic strategies

Extracellular Vesicles in Cancer Immune Microenvironment and Cancer Immunotherapy

Influencing immunity: role of extracellular vesicles in tumor immune checkpoint dynamics

Therapeutic roles of mesenchymal stem cell-derived extracellular vesicles in cancer

Tumor-derived Extracellular Vesicles: Regulators of Tumor Microenvironment and the Enlightenment in Tumor Therapy

Extracellular vesicles in the tumor immune microenvironment

Extracellular vesicles reshape the tumor microenvironment to improve cancer immunotherapy: Current knowledge and future prospects

The Crosstalk between Cancer Stem Cells and Microenvironment Is Critical for Solid Tumor Progression: The Significant Contribution of Extracellular Vesicles

Small Extracellular Vesicles-Mediated Cellular Interactions Between Tumor Cells and Tumor-Associated Macrophages: Implication for Immunotherapy.

Immune Cell-Derived Extracellular Vesicles – New Strategies in Cancer Immunotherapy

Extracellular vesicles in the tumor microenvironment: old stories, but new tales

Tumor endothelial cell-derived extracellular vesicles contribute to tumor microenvironment remodeling

Mesenchymal Stem Cell-Derived Extracellular Vesicles: Roles In Tumor Growth, Progression, And Drug Resistance